Main Menu
MSAA
  • Toll-Free Helpline Call Us Toll Free (800) 532-7667 Search
  • Get MS Updates
  • Información en Español
  • Donate
  • Skip main navigation
MSAA logo
  • MS Information
    • MS Overview & Glossary
    • Newly Diagnosed
    • Symptoms
    • Treatments
    • COVID-19 and MS
    • Patient Support Programs
    • Clinical Trials Search
    • Publications
    • Latest News from MSAA
    • Videos and Webinars
    • Podcasts from MSAA
    • Toll-free Helpline & Chat
    • Información en Español
    • MS FAQs and Glossary
  • How MSAA Can Help
    • Toll-free Helpline & Chat
    • Publications
    • Videos and Webinars
    • Cooling Products
    • Equipment Products
    • MRI Access Program
    • Educational Programs
    • Shared Decision-Making Tools
    • Overall Wellness
    • Online Aquatic Center
    • FAQs
  • Living with MS
    • My MSAA Community
    • MS Conversations Blog
    • Multiple Sclerosis Implementation Network™ (MSIN™)
    • My MS Journey
    • My MS Manager™ Mobile App
    • MS Relapse Resource Center
    • Overall Wellness
    • Online Aquatic Center
    • Educational Programs
  • Donate
    • Make A Donation
    • Honor and Memorial Donations
    • Become a Monthly Improver
    • Planned Giving
    • Other Ways to Give
      • Donor-Advised Funds
      • Vehicle Donation
      • Matching Gifts
      • Shop & Support MSAA
    • Donation FAQs
  • Get Involved
    • Special Events
    • Art Showcase
    • Do-It-Yourself Fundraiser
    • Multiple Sclerosis Implementation Network™ (MSIN™)
    • Partnerships
    • Volunteer With MSAA
    • FAQ
  • Calendar
  • About MSAA
    • Mission and Overview
    • MS Awareness Month
    • MSAA Achievements
    • Contact Us
    • Board of Directors
    • Healthcare Advisory Council
    • African American Advisory Board
    • Hispanic/Latinx Advisory Board
    • MSAA Strategic Plan
    • Navigating MS
    • MS Coalition
    • Annual Report
    • Financial Information
  • Search
  • Home
  • Bafiertam®
Back to Treatment Guide

Bafiertam®

monomethyl fumarate

Quick Facts

Bafiertam® (monomethyl fumarate) is a selective immunosuppressant with neuroprotective and immunomodulatory effects.

Capsule taken orally

Half-dose (95 mgs) taken twice daily for the first 7 days; then full maintenance dose (190 mgs) taken twice daily

Relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting MS, and active secondary-progressive MS

Potential Benefit:

The 190 mg dose of Bafiertam® (monomethyl fumarate) is similar to the 240 mg dose of Tecfidera® (dimethyl fumarate). Because of their similarities, results from the Tecfidera® clinical trials are used for Bafiertam®.

Clinical trial results for Tecfidera® compared to placebo:

  • Reduced annual relapse rate by 53%
  • MRI showed a 90% reduction of detectable brain lesions (Gd+ lesions) and 85% and T2 lesions
  • Slowed disability progression by 38%

Common Potential Side Effects

Flushing and stomach problems (especially at the start of therapy, and may decrease over time), redness, itching, rash, diarrhea.

Prescription Assistance:

Banner Patient Support >

For assistance finding additional resources that might help cover the costs of your prescription, contact MSAA.

Hear from the Expert
Augusto Miravalle, MD, FAAN
Advanced Neurology of Colorado
Clinical Associate Professor of Neurology
University of Colorado
Augusto Miravalle, MD, FAAN
"One of the challenges in MS care nowadays, is to be able to provide a comprehensive approach."

DRUGMAKER

Banner

HOW Bafiertam® WORKS

Bafiertam® acts similarly to the oral treatment Tecfidera (dimethyl fumarate), also known as DMF. DMF gets absorbed in the gastrointestinal (GI) tract, where it’s converted and becomes the active agent monomethyl fumarate (MMF). MMF has been shown to have neuroprotective and immunomodulatory effects.

FDA-Approved

Bafiertam® was FDA-approved in 2020 to treat relapsing forms of MS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary-progressive disease, in adults.

Potential Side Effects

Flushing and stomach problems are common, especially at the start of therapy, and may decrease over time; redness, itching, rash, or diarrhea may also occur.

Warnings, side effects, and adverse events are similar to those listed for Tecfidera®. Allergic reactions, progressive multifocal leukoencephalopathy (PML) – a rare brain infection that usually leads to death or severe disability over a period of weeks or months – serious infections, and liver injury, are among the potential adverse events.

OTHER KEY INFORMATION

Testing completed prior to starting Bafiertam® includes:

  • A complete blood count (CBC), including lymphocyte count.
  • Liver tests, including serum aminotransferase, alkaline phosphatase, and total bilirubin levels.

Testing completed after starting Bafiertam® includes:

  • CBC, including lymphocyte count, 6 months after initiation, and then every 6 to 12 months thereafter as directed by your physician.
  • Liver tests (serum aminotransferase, alkaline phosphatase, and total bilirubin levels) during treatment as directed by your physician.

When starting Bafiertam, please note there is a titration period (starting at a half dose and increasing to the full dose after the first 7 days).

Patient advocates talk about
their treatment experience

  • Kristie Salerno Kent
    MS Advocate, Patient Advocacy Consultant
    Kristie Salerno Kent
    “I have had situations where treatments aren’t approved at first. My doctors, nurses, they actually go to bat for me and made it happen.”
  • Azure Antoinette
    MS Advocate
    Azure Antoinette
    "I will be undergoing my first disease-modifying therapy to help treat multiple sclerosis in my body and while I’m very nervous, I am equally as excited and looking forward to the positive effects of how I will feel physically, and mentally, and emotionally."
  • Damian Washington
    MS Advocate
    Damian Washington
    “Nobody’s going to be looking out for your best interests better than you.”
  • Cathy Chester
    MS Advocate
    Cathy Chester
    “I think it’s really important to talk about how to age with this illness.”
  • Lauren Hutton-Work
    MS Advocate
    Lauren Hutton-Work
    “Just because you have this disease does not mean that your work life should be awkward or uncomfortable.”
  • Chernise Joseph
    MS Advocate
    Chernise Joseph
    “My first neurologist was a frontline neurologist, he wasn’t an MS specialist.”
  • Julian Gamboa
    MS Advocate
    Julian Gamboa
    “If you’re newly diagnosed with multiple sclerosis remember it’s always okay to get a second opinion.”
  • Lauren and Sam Alcorn
    MS Advocates
    Lauren and Sam Alcorn
    “Our future is uncertain and we have to enjoy each other and love each other in the present.”
  • Shawn Feliciano
    MS Advocate
    Shawn Feliciano
    “I want to know what medications might work best for someone who’s Hispanic.”
  • Darlene Feigen
    MS Advocate
    Darlene Feigen
    “The sooner you get on a therapy the better it is in the long run.”
  • Birgit Bauer
    MS Advocate
    Birgit Bauer
    “At the end of the appointment you should have an answer to the most important questions.”
  • Ellen Tutton
    MS Advocate
    Ellen Tutton
    “I looked up all the different disease-modifying therapies and compared them to my lifestyle.”
  • Victoria Marie Reese
    MS Advocate
    Victoria Marie Reese
    “I’m trying to show my daughter that taking care of yourself is cool.”
    • MSAA logo
    • (800) 532-7667
    • msaa@mymsaa.org
    • MSAA is a 501(C)(3) nonprofit registered in the US under EIN: 22-1912812.Copyright ©2025 Multiple Sclerosis Association of America.Reproduction of material from any mymsaa.org pages without written permission is strictly prohibited.
    • GET EMAIL UPDATES
    • Privacy Policy and Terms of Use
    • Donor Privacy Policy
    • Financial Information
    • Información en Español
    • Contact Us
    • GET SMS UPDATES:
      Text
      MSAA to 75101

       
      Why sign up?
      You’ll get important MS-related news, crucial updates about our programs, and easy ways to support the MS community right from your phone.
       
      By participating, you agree to the terms and privacy policy for recurring autodialed campaign & donation messages from MSAA to the phone number you provide. No consent required to buy. Message and data rates may apply.
    • Guidestar Logo
    • Charity Navigator
    • America's Charities
    • Facebook
    • Twitter
    • Instagram
    • Tik Tok
    • Pinterest
    • YouTube
    • LinkedIn
    • ESSENTIAL
    • Accessibility Statement

Oct 27, 2022 @ 12:28 pm

×